Edition

Matthew Herder

0

Director of the Health Justice Institute at the Schulich School of Law, Dalhousie University

Health Canada’s new drug licensing proposal contains no mechanism for making fast-tracked medicines affordable. THE CANADIAN PRESS/Ryan Remiorz

June 26, 2023

Canada’s misguided changes to drug regulation could fast‑track unproven medications and divert funds from other health needs

Steven G. Morgan, University of British Columbia; Aidan Hollis, University of Calgary; Christopher McCabe, Queen's University Belfast; Matthew Herder, Dalhousie University, and Mike Paulden, University of Alberta

The federal government’s proposed Agile Licensing drug approval regulations mean Canada will have less information about the risks of new medicines, and higher costs.

South Africans wait for access to a COVID-19 vaccine. (Shutterstock)

February 28, 2022

A South African company addresses vaccine supply inequity, despite Canada’s lack of support

Matthew Herder, Dalhousie University and E. Richard Gold, McGill University

New research sheds light on how Canadian researchers developed a key component of the mRNA COVID-19 vaccines but failed to share it with the world

Contact Matthew for

General
Media request
Speaking request
Consulting / Advising
Research collaboration
Research supervision

Location: Halifax, Canada
Website
BlueSky: @mattherder.bsky.social
Article Feed
ORCID
Joined January 23, 2021